创新医疗管理股份有限公司股票交易异常波动公告

Core Viewpoint - The stock of Innovation Medical Management Co., Ltd. has experienced abnormal trading fluctuations, with a cumulative closing price increase exceeding 20% over three consecutive trading days [2]. Group 1: Stock Trading Abnormalities - The company's stock (abbreviated as Innovation Medical, stock code: 002173) has shown a significant price deviation, qualifying it as an abnormal trading situation according to Shenzhen Stock Exchange regulations [2]. - The company has confirmed that there are no corrections or supplements needed for previously disclosed information [3][7]. Group 2: Company Verification and Operations - The company has verified with its controlling shareholders, actual controllers, directors, and senior management regarding the stock price fluctuations and found no undisclosed significant information affecting the stock price [3][4]. - There have been no major changes in the company's production and operational environment recently [4]. - The company and its controlling shareholders have not engaged in any stock trading during the period of abnormal fluctuations [6]. Group 3: Business Focus and Financial Performance - The company has noted increased market interest in its brain-computer interface business, particularly through its subsidiary, Boling Brain Machine (Hangzhou) Technology Co., Ltd., which was established in early 2021 and included in the consolidated financial statements in August 2025 [6]. - The main products are aimed at rehabilitation training for patients with cerebrovascular diseases, with the product "Cyberlink AC5" launched in October 2025 generating revenue of 114,000 yuan in that year [6]. - The company reported operating losses of 6.60 million yuan and 8.66 million yuan for the years 2023 and 2024, respectively [6].